A first generation selective estrogen receptor modulator (SERM). Like tamoxifen, it is an estrogen agonist for bone tissue and cholesterol metabolism but is antagonistic on mammary and uterine tissue. .

Z-Toremifene - Pharmacology:

Z-Toremifene is a nonsteroidal triphenylethylene derivative. Z-Toremifene binds to estrogen receptors and may exert estrogenic, antiestrogenic, or both activities, depending upon the duration of treatment, animal species, gender, target organ, or endpoint selected. The antitumor effect of toremifene in breast cancer is believed to be mainly due to its antiestrogenic effects, ie, its ability to compete with estrogen for binding sites in the cancer, blocking the growth-stimulating effects of estrogen in the tumor.

Z-Toremifene for patients

Patient Information:

Vaginal bleeding has been reported in patients using Z-Toremifene. Patients should be informed about
this and instructed to contact their physician if such bleeding occurs.

Patients with bone metastases should be informed about the typical signs and symptoms of hypercalcemia
and instructed to contact their physician for further assessment if such signs or symptoms occur.

Z-Toremifene Interactions

Drugs that decrease renal calcium excretion, eg, thiazide diuretics, may increase the risk of hypercalcemia in patients receiving FARESTON. There is a known interaction between antiestrogenic compounds of the triphenylethylene derivative class and coumarin-type anticoagulants (eg, warfarin), leading to an increased prothrombin time. When concomitant use of anticoagulants with FARESTON is necessary, careful monitoring of the prothrombin time is recommended.

Cytochrome P450 3A4 enzyme inducers, such as phenobarbital, phenytoin, and carbamazepine increase the rate of toremifene metabolism, lowering the steady-state concentration in serum. Metabolism of toremifene may be inhibited by drugs known to inhibit the CYP3A4-6 enzymes. Examples of such drugs are ketoconazole and similar antimycotics as well as erythromycin and similar macrolides. This interaction has not been studied and its clinical relevance is uncertain.

Z-Toremifene Contraindications

FARESTON is contraindicated in patients with known hypersensitivity to the drug.

Generic name, Overdose, Half Life Z-Toremifene, Food Interactions, Chemical, etc..

Z-Toremifene see also

Brand Names containing Toremifene

Chemical structure:
Cl N O H H H H H H H H H H H H H H H H H H H H H H H H H H H H C26H28ClNO 2D chemical structure C26H28ClNO SVG | 2D structure Toremifene | Clomifene | chemical names, chemical properties, classification C26H28ClNO